Pacific Center for Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9K Hold
14
﹤0.01% 307
2025
Q4
$10.7K Hold
14
﹤0.01% 318
2025
Q3
$10.7K Hold
14
﹤0.01% 318
2025
Q2
$10.9K Hold
14
﹤0.01% 301
2025
Q1
$11.6K Sell
14
-1
-7% -$832 ﹤0.01% 296
2024
Q4
$11.6K Buy
15
+1
+7% +$828 ﹤0.01% 296
2024
Q3
$12.4K Hold
14
﹤0.01% 288
2024
Q2
$12.7K Hold
14
﹤0.01% 281
2024
Q1
$10.9K Buy
+14
New +$9.96K ﹤0.01% 292
2018
Q1
Sell
-120
Closed -$10K 310
2017
Q4
$10K Buy
+120
New +$10.2K 0.01% 203

Other funds holding LLY

Pacific Center for Financial Services's LLY Position: Q1 2026 in Review

Pacific Center for Financial Services held its Eli Lilly (LLY) position steady in Q1 2026 at 14 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #307.

Pacific Center for Financial Services first reported a position in LLY in Q4 2017 and has held it in 10 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pacific Center for Financial Services held 14 shares of Eli Lilly worth $12.9K as of Q1 2026.
  • Pacific Center for Financial Services left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up ﹤0.01% of Pacific Center for Financial Services's portfolio in Q1 2026, its #307 holding.
  • Pacific Center for Financial Services first reported a position in Eli Lilly in Q4 2017 and has held it in 10 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pacific Center for Financial Services's 13F filing for Q1 2026, filed 12 May 2026.